INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 90S90 trades$362K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,797 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 15, 2026
Page 1451 of 1795
← PrevNext →
Jan 16, 2026
traded Jan 15, 2026
+1d
SEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
5,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
1,407 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
DA
D'Amico AndrewDirector
VICRVICOR CORP
Option exercise · 10b5-1 plan
M$20K
200 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Grant or award · 10b5-1 plan
A—
300.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$94K
2,678 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
2,678 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$25K
1,407 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
5,893 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
IR
Inukonda RaviCHIEF FINANCIAL OFFICER
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M—
1,017 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

0
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Grant or award · 10b5-1 plan
A—
44.7K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
62.5K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
250.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
250.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$2,446
321 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

56
MJ
McNally Kevin JosephTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$5,135
634 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

56
VW
Versaci Vincent WTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$11K
1,336 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

52
VW
Versaci Vincent WTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$3,016
371 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

50
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$3.91M
11.6K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

48
NR
Neufeld Leah RCHIEF PEOPLE OFFICER
IMRXImmuneering Corp
Open-market purchase
BUY$11K
2,626 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

48
WJ
Weber Clifford JohnTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$8,160
1,000 sh
Jan 15, 2026Jan 15, 2026
traded Jan 15, 2026
+0dSEC Form 4

Evidence

47
GO
Gayle OswaldChief Financial Officer
LUCYInnovative Eyewear Inc
Open-market purchase
BUY$1,162
700 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

46
MJ
McNally Kevin JosephTrustee
GLVClough Global Dividend & Income Fund
Open-market purchase
BUY$6,240
1,000 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

44
KC
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$2.87M
100.0K sh
Jan 15, 2026Jan 15, 2026
traded Jan 15, 2026
+0dSEC Form 4

Evidence

44
EW
Eager William WPresident, S&P Global Mobility
SPGIS&P Global Inc.
Open-market purchase
BUY$5,954
11 sh
Sep 10, 2025Jan 15, 2026
traded Sep 10, 2025
+127dSEC Form 4

Evidence

43
GO
Gayle OswaldChief Financial Officer
LUCYInnovative Eyewear Inc
Open-market purchase
BUY$507
300 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

43
SC
Stokes CameronSee Remarks
LAKELAKELAND INDUSTRIES INC
Open-market purchase
BUY$4,244
450 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

42
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$1.27M
3,780 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

42
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$2.64M
7,820 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

42
WJ
Weber Clifford JohnTrustee
GLOClough Global Opportunities Fund
Open-market purchase
BUY$6,000
1,000 sh
Jan 15, 2026Jan 15, 2026
traded Jan 15, 2026
+0dSEC Form 4

Evidence

40
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$8.31M
96.0K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

38
DP
Donohoe Bryan PatrickChief Executive Officer
ACREAres Commercial Real Estate Corp
Open-market sale
SELL$107K
21.8K sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

36
TC
Tkach CameronExecutive Vice President, COO
RDNWRideNow Group, Inc.
Open-market sale
SELL$3,664
745 sh
Jan 2, 2025Jan 15, 2026
traded Jan 2, 2025
+378dSEC Form 4

Evidence

35
EW
Eager William WPresident, S&P Global Mobility
SPGIS&P Global Inc.
Open-market purchase
BUY$5,964
12 sh
Dec 10, 2025Jan 15, 2026
traded Dec 10, 2025
+36dSEC Form 4

Evidence